Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Search
Main sub menu
Investors
Careers
Working at Recipharm
The Recipharm story
Meet our employees
Current vacancies
Contact
Contact us
Development services contacts
Manufacturing services contacts
Locations
France
Fontaine
Kaysersberg
Monts
Pessac
Germany
Monheim
Wasserburg
Zwickau
India
Bengaluru
Karnal / Paonta Sahib
Israel
Ness Ziona
Italy
Brescia
Lainate
Masate
Paderno Dugnano
Pianezza
Portugal
Odivelas
Queluz
Spain
Parets
Leganés
Sweden
Höganäs
Stockholm city (HQ)
Karlskoga
Solna
Strängnäs
Uppsala
Uppsala Development
UK
Cramlington
Holmes Chapel
Queenborough
King’s Lynn
USA
Research Triangle Park
Main navigation
Development
Drug substance
Drug product
Analytical chemistry
Clinical trial material (CTM)
Manufacturing
Solids
Semi-solids
Liquids
Inhalation
Injectables
Ophthalmics
Solutions
Recipharm Analytical Solutions™
Recipharm Inhalation Solutions™
Recipharm Pathway to Clinic®
Serialisation
Bespak
Learn
Press & events
Press
Events
Reports
Insights
Our story
Recipharm in brief
Business model
Sustainability
Company history
Press & events
What's happening?
Stay updated on our latest news and events.
Press and Event
Press
Events
Reports
Insights
Displaying 31 - 40 of 406
Subscribe
Show all
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Press
Recipharm doubles EBIT and expects second quarter results to be stronger than analyst consensus
2020.07.13
Read more
Press
Change in the total number of shares and votes in Recipharm AB (publ)
2020.06.30
Read more
Press
Recipharm announces final result of the oversubscribed rights issue
2020.06.25
Read more
Press
Recipharm announces the preliminary outcome of the oversubscribed rights issue
2020.06.24
Read more
Press
Recipharm publishes prospectus
2020.06.04
Read more
Press
Change in the total number of shares and votes in Recipharm AB (publ)
2020.05.29
Read more
Press
The Board of Directors of Recipharm resolves on a rights issue of approximately SEK 2,017 million and announces the terms
2020.05.27
Read more
Press
Recipharm to present at Jefferies 2020 Virtual Healthcare Conference
2020.05.26
Read more
Press
Recipharm has carried out a directed share issue of 4,524,886 class B shares and is hereby provided with proceeds of SEK around 500 million
2020.05.19
Read more
Press
Recipharm to present at the 2020 UBS Virtual Global Healthcare Conference
2020.05.18
Read more
Pagination
First page
« First
Previous page
‹ Previous
Page
1
Page
2
Page
3
Current page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next ›
Last page
Last »